Fibrosis in hepatitis c patients predicts complications after elective total joint arthroplasty

Journal of Arthroplasty

Volumn 29, Issue 1, 2014, Pages 7-10

  Orozco, Fabio ^a   Post, Zachary D ^a   Baxi, Omkar ^b   Miller, Adam ^a   Ong, Alvin ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Complications; Fibrosis; Hepatitis C; Outcomes; Total joint arthroplasty

Indexed keywords

HEMOGLOBIN;

ARTICLE; CELLULITIS; CONTROLLED STUDY; DEBRIDEMENT; ELECTIVE TOTAL JOINT ARTHROPLASTY; FEMALE; FIBROSIS; HEMATOMA; HEPATITIS C; HUMAN; INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; REOPERATION; RETROSPECTIVE STUDY; RISK; THROMBOCYTOPENIA; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

COMPLICATIONS; FIBROSIS; HEPATITIS C; OUTCOMES; TOTAL JOINT ARTHROPLASTY;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; FIBROSIS; HEPATITIS C; HUMANS; JOINT DISEASES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 84889078348     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.03.023     Document Type: Article

References (17)

1. Ghany M.G., Strader D.B., Thomas D.L., et al. AASLD Practice Guidelines: Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009, 49(4):1335.
2. Villani C., Conte S., Chiozzi F., et al. Prevalence of hepatitis B and hepatitis C in an orthopedics and traumatology ward. Chir Organi Mov 2001, 86(2):167.
3. Rosen H.R. Chronic Hepatitis C Infection. N Engl J Med 2011, 364:2429.
4. Smith J.O., Sterling R.K. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther 2009, 30(6):557.
5. Cohen S.M., Te Hs Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty 2005, 20(4):460.
6. Shih L.Y., Cheng C.Y., Chang C.H., et al. Total knee arthroplasty in patients with liver cirrhosis. J Bone Joint Surg Am 2004, 86(2):335.
7. Suman A., Carey W. Assessing the risk of surgery in patients with liver disease. Cleve Clin J Med 2006, 73(4):398.
8. Friedman L. The risk of surgery in patients with liver disease. Hepatology 1999, 29(6):1617.
9. Pour A.E., Matar W.Y., Jafari S.M., et al. Total joint arthroplasty in patients with hepatitis C. J Bone Joint Surg Am 2011, 93(15):1448.
10. Olariu M., Olariu C., Olteanu D. Thrombocytopenia in chronic hepatitis C. J Gastrointestin Liver Dis 2010, 19(4):381.
11. Louie K.S., Micallef J.M., Pimenta J.M., et al. Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review. J Viral Hepat 2011, 18(1):1.
12. Smith B., et al. Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945-1965. Morb Mortal Wkly Rep 2012, 61(RR04):1.
13. Carole B., Cheung R., Giori N. Prevalence of hepatitis C virus infection in the veteran population undergoing total joint arthroplasty. J Arthroplasty 2012, 27(10):1772.
14. Smyth S., et al. Platelet functions beyond hemostasis. J Thromb Hemost 2009, 7:1759.
15. Hsieh P., et al. Hip arthroplasty in patients with cirrhosis of the liver. J Bone Joint Surg 2003, 85(6):818.
16. Hsieh P., et al. Prosthetic hip infection in patients with hip cirrhosis: an outcome analysis. Int J Infect Dis 2010, 14(12):e1054.
17. Moon Y., et al. Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease. J Korean Med Sci 2007, 22(2):223.